Filtered By:
Cancer: Liver Cancer
Management: WHO
This page shows you your search results in order of date.
Order by Relevance | Date
Total 262 results found since Jan 2013.
Blueprint to hepatitis B elimination in China: A modelling analysis of clinical strategies
CONCLUSIONS: Eliminating HBV will require interventional strategies to improve diagnostic, linkage-to-care, and treatment coverages. Developing novel therapies will be crucial in further reducing HBV-related mortality and removing HBV as a public health threat.IMPACT AND IMPLICATIONS: This study explores the key developments and optimal intervention strategies needed to achieve WHO hepatitis B elimination targets by 2030 in China. It highlights that China can realise the HBV elimination targets in the incidence by 2025, and by upscaling diagnostic, linkage-to-care, and treatment coverages, up to 2 million lives could poten...
Source: Cancer Control - September 7, 2023 Category: Cancer & Oncology Authors: Rui Li Mingwang Shen Jason J Ong Fuqiang Cui Wenyi Hu Polin Chan Zhuoru Zou Shu Su Hangting Liu Lei Zhang Wai-Kay Seto William C W Wong Source Type: research
Ligand-mediated Targeted Drug Delivery Approaches against Hepatocellular Carcinoma
Curr Cancer Drug Targets. 2023;23(11):879-888. doi: 10.2174/1568009623666230503094346.ABSTRACTOne of the most important health problems in the world today is cancer. The World Health Organization (WHO) reported that it results in 8.9 million deaths annually. Malignant tumours and unregulated cell proliferation are features of malignant neoplasms, which can also invade nearby body regions. Hepatocellular carcinoma is the third most prevalent cause of cancer-related death worldwide and the fifth most common kind of cancer, according to a recent analysis. Patients with liver disease as well as chronic hepatitis B and C are mo...
Source: Current Cancer Drug Targets - September 1, 2023 Category: Cancer & Oncology Authors: Amrita Singh Sudhanshu Mishra Saurabh Sharma Smriti Ojha Sunil Yagnik Sudhi Pandey Source Type: research
PLU1 Promotes the Proliferation and Migration of Glioma Cells and Regulates Metabolism
CONCLUSION: PLU1 is a novel regulator of metabolic reprograming and a novel strategy for the treatment of glioma.PMID:37254514 | DOI:10.1177/15330338231175768
Source: Cell Research - May 31, 2023 Category: Cytology Authors: Wentao Dong Lude Wang Yi Pan Qi Tu Ting He Tian Zhou Jianlie Yuan Minfeng Tong Source Type: research
Evaluation and Prediction of Treatment Response for Hepatocellular Carcinoma
Magn Reson Med Sci. 2023 Feb 16. doi: 10.2463/mrms.rev.2022-0118. Online ahead of print.ABSTRACTThe incidence of hepatocellular carcinoma (HCC) is still on the rise in North America and Europe and is the second leading cause of cancer-related mortality. The treatment of HCC varies, with surgery and locoregional therapy (LRT) such as radiofrequency ablation and transcatheter arterial chemoembolization, and radiation therapy being the primary treatment. Currently, systemic therapy with molecular-targeted agents and immune checkpoint inhibitors (ICIs) is becoming a major treatment option for the unresectable HCC. As the HCC a...
Source: Magnetic Resonance in Medical Sciences : MRMS - February 15, 2023 Category: Radiology Authors: Yushi Tsujita Keitaro Sofue Eisuke Ueshima Yoshiko Ueno Masatoshi Hori Masakatsu Tsurusaki Takamichi Murakami Source Type: research
